The Effects of 3D Immersion Technology (3Scape) on Mental Health in Outpatients From a Short-Term Assessment, Rehabilitation, and Treatment Program: Feasibility Protocol for a Randomized Controlled Trial
BackgroundMental health conditions are prevalent among Canadians and are a leading cause of disability. Each year, 1 in 5 Canadians experiences a mental health issue. A total of 5% of people aged ≥65 years perceive their mental health as fair or poor, and 6.3% of them have mo...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
JMIR Publications
2021-09-01
|
| Series: | JMIR Research Protocols |
| Online Access: | https://www.researchprotocols.org/2021/9/e25017 |
| _version_ | 1797735737787940864 |
|---|---|
| author | Antonio Miguel-Cruz Anna-Maria Ladurner Megan Kohls-Wiebe David Rawani |
| author_facet | Antonio Miguel-Cruz Anna-Maria Ladurner Megan Kohls-Wiebe David Rawani |
| author_sort | Antonio Miguel-Cruz |
| collection | DOAJ |
| description |
BackgroundMental health conditions are prevalent among Canadians and are a leading cause of disability. Each year, 1 in 5 Canadians experiences a mental health issue. A total of 5% of people aged ≥65 years perceive their mental health as fair or poor, and 6.3% of them have mood disorders. Regarding older adults with cognitive impairments such as dementia, up to 40%-50% of them experience depression at some point. We believe that older adults can benefit significantly from information and telecommunication technologies as a strategy for improving mental health conditions such as depression and anxiety, while simultaneously improving their quality of life. 3Scape Systems Inc is an Alberta-based private company that has produced a series of specialized 3D videos designed to simulate real-life events and engage individuals living with mental health disorders and cognitive impairments such as dementia.
ObjectiveThis study aims to explore the trial design and effects of 3Scape videos on older adults’ symptoms of depression and anxiety and the efficacy of this technology in improving the quality of life of patients attending the Short-Term Assessment, Rehabilitation, and Treatment Psychiatry Day Hospital program at Glenrose Rehabilitation Hospital and to provide data to estimate the parameters required to design a definitive randomized controlled trial.
MethodsThe trial will use a randomized controlled design comprising 15 intervention participants and 15 control group participants. The participants will be adults aged ≥65 years who are cognitively intact or have minimal cognitive impairment (ie, Montreal Cognitive Assessment score ≥18), and are clients of the Short-Term Assessment, Rehabilitation, and Treatment Psychiatry Day Hospital program at Glenrose Rehabilitation Hospital. This study’s primary outcome variables are related to clients’ depressive and anxiety symptoms and their quality of life. The control group will receive the standard of care (ie, the Short-Term Assessment, Rehabilitation, and Treatment Psychiatry Day Hospital program at Glenrose Rehabilitation Hospital). The intervention group will receive the same standard of care as the control group and will use 3Scape Systems videos for therapeutic activities.
ResultsOur study is currently on hold because of the COVID-19 pandemic. The recruitment process is expected to resume by November 2021, and the primary impact analysis is expected to be conducted by February 2022.
ConclusionsThis study will provide valuable information such as the measurement of comparative intervention effects, perception of older adults and mental health therapists about the 3Scape Systems, the associated costs of treatment, and product costs. This will contribute to the evidence planning process, which will be crucial for the future adoption of 3Scape Systems.
Trial RegistrationInternational Standard Randomized Controlled Trial Number (ISRCTN): 93685907; https://www.isrctn.com/ISRCTN93685907.
International Registered Report Identifier (IRRID)PRR1-10.2196/25017 |
| first_indexed | 2024-03-12T13:03:26Z |
| format | Article |
| id | doaj.art-620614309b874f6884acdb40e81df7e0 |
| institution | Directory Open Access Journal |
| issn | 1929-0748 |
| language | English |
| last_indexed | 2024-03-12T13:03:26Z |
| publishDate | 2021-09-01 |
| publisher | JMIR Publications |
| record_format | Article |
| series | JMIR Research Protocols |
| spelling | doaj.art-620614309b874f6884acdb40e81df7e02023-08-28T19:03:15ZengJMIR PublicationsJMIR Research Protocols1929-07482021-09-01109e2501710.2196/25017The Effects of 3D Immersion Technology (3Scape) on Mental Health in Outpatients From a Short-Term Assessment, Rehabilitation, and Treatment Program: Feasibility Protocol for a Randomized Controlled TrialAntonio Miguel-Cruzhttps://orcid.org/0000-0003-1618-8733Anna-Maria Ladurnerhttps://orcid.org/0000-0003-3182-4478Megan Kohls-Wiebehttps://orcid.org/0000-0001-5020-5950David Rawanihttps://orcid.org/0000-0003-1000-5238 BackgroundMental health conditions are prevalent among Canadians and are a leading cause of disability. Each year, 1 in 5 Canadians experiences a mental health issue. A total of 5% of people aged ≥65 years perceive their mental health as fair or poor, and 6.3% of them have mood disorders. Regarding older adults with cognitive impairments such as dementia, up to 40%-50% of them experience depression at some point. We believe that older adults can benefit significantly from information and telecommunication technologies as a strategy for improving mental health conditions such as depression and anxiety, while simultaneously improving their quality of life. 3Scape Systems Inc is an Alberta-based private company that has produced a series of specialized 3D videos designed to simulate real-life events and engage individuals living with mental health disorders and cognitive impairments such as dementia. ObjectiveThis study aims to explore the trial design and effects of 3Scape videos on older adults’ symptoms of depression and anxiety and the efficacy of this technology in improving the quality of life of patients attending the Short-Term Assessment, Rehabilitation, and Treatment Psychiatry Day Hospital program at Glenrose Rehabilitation Hospital and to provide data to estimate the parameters required to design a definitive randomized controlled trial. MethodsThe trial will use a randomized controlled design comprising 15 intervention participants and 15 control group participants. The participants will be adults aged ≥65 years who are cognitively intact or have minimal cognitive impairment (ie, Montreal Cognitive Assessment score ≥18), and are clients of the Short-Term Assessment, Rehabilitation, and Treatment Psychiatry Day Hospital program at Glenrose Rehabilitation Hospital. This study’s primary outcome variables are related to clients’ depressive and anxiety symptoms and their quality of life. The control group will receive the standard of care (ie, the Short-Term Assessment, Rehabilitation, and Treatment Psychiatry Day Hospital program at Glenrose Rehabilitation Hospital). The intervention group will receive the same standard of care as the control group and will use 3Scape Systems videos for therapeutic activities. ResultsOur study is currently on hold because of the COVID-19 pandemic. The recruitment process is expected to resume by November 2021, and the primary impact analysis is expected to be conducted by February 2022. ConclusionsThis study will provide valuable information such as the measurement of comparative intervention effects, perception of older adults and mental health therapists about the 3Scape Systems, the associated costs of treatment, and product costs. This will contribute to the evidence planning process, which will be crucial for the future adoption of 3Scape Systems. Trial RegistrationInternational Standard Randomized Controlled Trial Number (ISRCTN): 93685907; https://www.isrctn.com/ISRCTN93685907. International Registered Report Identifier (IRRID)PRR1-10.2196/25017https://www.researchprotocols.org/2021/9/e25017 |
| spellingShingle | Antonio Miguel-Cruz Anna-Maria Ladurner Megan Kohls-Wiebe David Rawani The Effects of 3D Immersion Technology (3Scape) on Mental Health in Outpatients From a Short-Term Assessment, Rehabilitation, and Treatment Program: Feasibility Protocol for a Randomized Controlled Trial JMIR Research Protocols |
| title | The Effects of 3D Immersion Technology (3Scape) on Mental Health in Outpatients From a Short-Term Assessment, Rehabilitation, and Treatment Program: Feasibility Protocol for a Randomized Controlled Trial |
| title_full | The Effects of 3D Immersion Technology (3Scape) on Mental Health in Outpatients From a Short-Term Assessment, Rehabilitation, and Treatment Program: Feasibility Protocol for a Randomized Controlled Trial |
| title_fullStr | The Effects of 3D Immersion Technology (3Scape) on Mental Health in Outpatients From a Short-Term Assessment, Rehabilitation, and Treatment Program: Feasibility Protocol for a Randomized Controlled Trial |
| title_full_unstemmed | The Effects of 3D Immersion Technology (3Scape) on Mental Health in Outpatients From a Short-Term Assessment, Rehabilitation, and Treatment Program: Feasibility Protocol for a Randomized Controlled Trial |
| title_short | The Effects of 3D Immersion Technology (3Scape) on Mental Health in Outpatients From a Short-Term Assessment, Rehabilitation, and Treatment Program: Feasibility Protocol for a Randomized Controlled Trial |
| title_sort | effects of 3d immersion technology 3scape on mental health in outpatients from a short term assessment rehabilitation and treatment program feasibility protocol for a randomized controlled trial |
| url | https://www.researchprotocols.org/2021/9/e25017 |
| work_keys_str_mv | AT antoniomiguelcruz theeffectsof3dimmersiontechnology3scapeonmentalhealthinoutpatientsfromashorttermassessmentrehabilitationandtreatmentprogramfeasibilityprotocolforarandomizedcontrolledtrial AT annamarialadurner theeffectsof3dimmersiontechnology3scapeonmentalhealthinoutpatientsfromashorttermassessmentrehabilitationandtreatmentprogramfeasibilityprotocolforarandomizedcontrolledtrial AT megankohlswiebe theeffectsof3dimmersiontechnology3scapeonmentalhealthinoutpatientsfromashorttermassessmentrehabilitationandtreatmentprogramfeasibilityprotocolforarandomizedcontrolledtrial AT davidrawani theeffectsof3dimmersiontechnology3scapeonmentalhealthinoutpatientsfromashorttermassessmentrehabilitationandtreatmentprogramfeasibilityprotocolforarandomizedcontrolledtrial AT antoniomiguelcruz effectsof3dimmersiontechnology3scapeonmentalhealthinoutpatientsfromashorttermassessmentrehabilitationandtreatmentprogramfeasibilityprotocolforarandomizedcontrolledtrial AT annamarialadurner effectsof3dimmersiontechnology3scapeonmentalhealthinoutpatientsfromashorttermassessmentrehabilitationandtreatmentprogramfeasibilityprotocolforarandomizedcontrolledtrial AT megankohlswiebe effectsof3dimmersiontechnology3scapeonmentalhealthinoutpatientsfromashorttermassessmentrehabilitationandtreatmentprogramfeasibilityprotocolforarandomizedcontrolledtrial AT davidrawani effectsof3dimmersiontechnology3scapeonmentalhealthinoutpatientsfromashorttermassessmentrehabilitationandtreatmentprogramfeasibilityprotocolforarandomizedcontrolledtrial |